H.Res. 1285: Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

H.Res. 1285 is a federal bill in the 119th Congress. See its sponsors, how members voted, and a plain-English breakdown on PolityLens.